This federal contract award, SPE2DB22D3016|SPE2DB25FAFX6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,560.39 award is for the delivery of 4,566,676,485 units of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting.
The contract has a firm fixed-price pricing type and a completion date of December 11, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.
Generated 3/11/25, 9:49 AM